Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. General Cardiovascular Medicine

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1683944

This article is part of the Research TopicNutraceuticals Modulation for Oxidative Stress in Disease and Health: Volume IIView all 4 articles

Investigation of the effect of quercetin on experimental traumatic cardiac injury in rats

Provisionally accepted
Muhammed  Enes TaysıMuhammed Enes Taysı1*Mustafa  Enes DemirelMustafa Enes Demirel2Ayhan  ÇetinkayaAyhan Çetinkaya2Aslıhan  ŞaylanAslıhan Şaylan2Seyit Ali  KAYISSeyit Ali KAYIS2Murat  AlışıkMurat Alışık2
  • 1TC Saglik Bakanligi Cankiri Devlet Hastanesi, Çankırı, Türkiye
  • 2Bolu Abant Izzet Baysal Universitesi Tip Fakultesi, Bolu, Türkiye

The final, formatted version of the article will be published soon.

Background: Cardioprotection is an important aspect of preventive medicine. Quercetin, a plant-derived flavonoid with antioxidant and anti-inflammatory properties, has been linked to reduced cardiovascular risk. Objective: To investigate the cardioprotective effects of quercetin in rats with traumatic cardiac injury (TCI). Methods: Fifty-two Wistar Albino rats were randomly divided into six groups: control (n=7); TCI only (n=9); TCI+DMSO (n=6); and TCI+quercetin at 10, 20, or 40 mg/kg (n=9 each). Quercetin or DMSO was given intraperitoneally at 0.5, 12, and 24 h after trauma. Cardiac trauma was induced by dropping a standardized weight on the chest. Serum biochemical parameters (GPx, SOD, IL-1, IL-33, sST2, MDA) were measured by ELISA, and histopathological damage was scored semiquantitatively. Data were analyzed using ANOVA or Kruskal–Wallis tests with p<0.05 as significant. Results: GPx elevation was detected only at 10 and 20 mg/kg (vs TCI; p < 0.05); 40 mg/kg was non-significant (p > 0.05). Overall, IL-1 differed among groups (p = 0.008), with no pairwise comparisons significant after correction (all p > 0.05). For IL-33, an overall group effect was observed (p = 0.025), while adjusted pairwise tests did not show a consistent between-group pattern (p > 0.05). In contrast, malondialdehyde (MDA) levels were significantly reduced, particularly at the highest dose of 40 mg/kg (p < 0.05). Superoxide dismutase (SOD) and soluble suppression of tumorigenicity-2 (sST2) levels showed no significant differences among groups (p > 0.05). Histopathological evaluation demonstrated that quercetin mitigated myocardial degeneration, inflammatory infiltration, edema, vascular congestion, hemorrhage, and necrosis in a dose-dependent manner, with the most pronounced protective effects observed at 40 mg/kg (p < 0.05). Conclusions: Quercetin, especially at 40 mg/kg, may help prevent secondary cardiac injury after trauma by reducing oxidative stress and limiting histopathological damage. These results support quercetin’s cardioprotective potential and warrant confirmation in larger preclinical models with broader designs.

Keywords: antioxidant, Blunt cardiac injury, interleukin-33, Malondialdehyde, Quercetin, rat

Received: 11 Aug 2025; Accepted: 13 Oct 2025.

Copyright: © 2025 Taysı, Demirel, Çetinkaya, Şaylan, KAYIS and Alışık. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Muhammed Enes Taysı, enestaysi65@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.